BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wei H, Sang LX, Chang B. Elafibranor: A promising treatment for alcohol-associated liver disease? World J Gastroenterol 2024; 30(39): 4313-4317 [PMID: 39492824 DOI: 10.3748/wjg.v30.i39.4313]
URL: https://www.wjgnet.com/1007-9327/full/v30/i39/4313.htm
Number Citing Articles
1
Samira Farhadi, Saeed Mohammadi, Abdulaziz Y AlKindi, Issa S Al-Amri. Therapeutic potential of elafibranor in alcohol-associated liver disease: Insights into macrophage modulation and fibrosis reductionWorld Journal of Biological Chemistry 2025; 16(1): 104535 doi: 10.4331/wjbc.v16.i1.104535